One-year-old Harper Hanki has won a “lottery” being run by a pharmaceutical company to receive a multi-million dollar treatment for spinal muscular atrophy. #ab#alberta@HankiHarper
https://t.co/Av0BZYq7vN
Medical advancements have drastically changed the prognosis for children born with Spinal Muscular Atrophy (SMA) in recent years, and soon more Canadian babies will be screened at birth for the genetic disease.
NEW:
Health Canada approves Zolgensma, the one-time gene therapy for young kids with spinal muscular atrophy (SMA).
Known as the world's most expensive drug, it previously required Canadian families to fundraise the $1.8M price tag.
#yeg#yyc#ableg#cdnpoli
Have you met @HankiHarper?
She's suffering from a very rare, life-threatening illness that will claim her life if she doesn’t receive treatment within the year. https://t.co/i2kCe8UYxV